Sequence of KMO_HUMAN
EC Number:1.14.13.9
EC Number
Recommended Name
Accession Code
Organism
No of amino acids
Molecular Weight [Da]
Source
Reaction
L-kynurenine + NADPH + H+ + O2 = 3-hydroxy-L-kynurenine + NADP+ + H2O
Other sequences found for EC No. 1.14.13.9
General information:
Sequence
0 MDSSVIQRKK VAVIGGGLVG SLQACFLAKR NFQIDVYEAR EDTRVATFTR GRSINLALSH
60 RGRQALKAVG LEDQIVSQGI PMRARMIHSL SGKKSAIPYG TKSQYILSVS RENLNKDLLT
120 AAEKYPNVKM HFNHRLLKCN PEEGMITVLG SDKVPKDVTC DLIVGCDGAY STVRSHLMKK
180 PRFDYSQQYI PHGYMELTIP PKNGDYAMEP NYLHIWPRNT FMMIALPNMN KSFTCTLFMP
240 FEEFEKLLTS NDVVDFFQKY FPDAIPLIGE KLLVQDFFLL PAQPMISVKC SSFHFKSHCV
300 LLGDAAHAIV PFFGQGMNAG FEDCLVFDEL MDKFSNDLSL CLPVFSRLRI PDDHAISDLS
360 MYNYIEMRAH VNSSWFIFQK NMERFLHAIM PSTFIPLYTM VTFSRIRYHE AVQRWHWQKK
420 VINKGLFFLG SLIAISSTYL LIHYMSPRSF LRLRRPWNWI AHFRNTTCFP AKAVDSLEQI
480 SNLISR
Download this sequence
Download all sequences for 1.14.13.9
Sequence related references
Sequence Reference
Authors
Title
Journal
Volume
Pages
Year
PubMed ID
562288
Alberati-Giani D.,Cesura A.M.,Broger C.,Warren W.D.,Rover S.,Malherbe P.
Cloning and functional expression of human kynurenine 3-monooxygenase.
FEBS Lett.
410
407-412
1997
562289
Breton J.,Avanzi N.,Magagnin S.,Covini N.,Magistrelli G.,Cozzi L.,Isacchi A.
Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase.
Eur. J. Biochem.
267
1092-1099
2000
562290
Gregory S.G.,Barlow K.F.,McLay K.E.,Kaul R.,Swarbreck D.,Dunham A.,Scott C.E.,Howe K.L.,Woodfine K.,Spencer C.C.A.,Jones M.C.,Gillson C.,Searle S.,Zhou Y.,Kokocinski F.,McDonald L.,Evans R.,Phillips K.,Atkinson A.,Cooper R.,Jones C.,Hall R.E.,Andrews T.D.,Lloyd C.,Ainscough R.,Almeida J.P.,Ambrose K.D.,Anderson F.,Andrew R.W.,Ashwell R.I.S.,Aubin K.,Babbage A.K.,Bagguley C.L.,Bailey J.,Beasley H.,Bethel G.,Bird C.P.,Bray-Allen S.,Brown J.Y.,Brown A.J.,Buckley D.,Burton J.,Bye J.,Carder C.,Chapman J.C.,Clark S.Y.,Clarke G.,Clee C.,Cobley V.,Collier R.E.,Corby N.,Coville G.J.,Davies J.,Deadman R.,Dunn M.,Earthrowl M.,Ellington A.G.,Errington H.,Frankish A.,Frankland J.,French L.,Garner P.,Garnett J.,Gay L.,Ghori M.R.J.,Gibson R.,Gilby L.M.,Gillett W.,Glithero R.J.,Grafham D.V.,Griffiths C.,Griffiths-Jones S.,Grocock R.,Hammond S.,Harrison E.S.I.,Hart E.,Haugen E.,Heath P.D.,Holmes S.,Holt K.,Howden P.J.,Hunt A.R.,Hunt S.E.,Hunter G.,Isherwood J.,James R.,Johnson C.,Johnson D.,Joy A.,Kay M.,Kershaw J.K.,Kibukawa M.,Kimberley A.M.,King A.,Knights A.J.,Lad H.,Laird G.,Lawlor S.,Leongamornlert D.A.,Lloyd D.M.,Loveland J.,Lovell J.,Lush M.J.,Lyne R.,Martin S.,Mashreghi-Mohammadi M.,Matthews L.,Matthews N.S.W.,McLaren S.,Milne S.,Mistry S.,Moore M.J.F.,Nickerson T.,O'Dell C.N.,Oliver K.,Palmeiri A.,Palmer S.A.,Parker A.,Patel D.,Pearce A.V.,Peck A.I.,Pelan S.,Phelps K.,Phillimore B.J.,Plumb R.,Rajan J.,Raymond C.,Rouse G.,Saenphimmachak C.,Sehra H.K.,Sheridan E.,Shownkeen R.,Sims S.,Skuce C.D.,Smith M.,Steward C.,Subramanian S.,Sycamore N.,Tracey A.,Tromans A.,Van Helmond Z.,Wall M.,Wallis J.M.,White S.,Whitehead S.L.,Wilkinson J.E.,Willey D.L.,Williams H.,Wilming L.,Wray P.W.,Wu Z.,Coulson A.,Vaudin M.,Sulston J.E.,Durbin R.M.,Hubbard T.,Wooster R.,Dunham I.,Carter N.P.,McVean G.,Ross M.T.,Harrow J.,Olson M.V.,Beck S.,Rogers J.,Bentley D.R.
The DNA sequence and biological annotation of human chromosome 1.
Nature
441
315-321
2006
562291
Stone T.W.,Darlington L.G.
Endogenous kynurenines as targets for drug discovery and development.
Nat. Rev. Drug Discov.
1
609-620
2002
562292
Amaral M.,Levy C.,Heyes D.J.,Lafite P.,Outeiro T.F.,Giorgini F.,Leys D.,Scrutton N.S.
Structural basis of kynurenine 3-monooxygenase inhibition.
Nature
496
382-385
2013
562293
Mole D.J.,Webster S.P.,Uings I.,Zheng X.,Binnie M.,Wilson K.,Hutchinson J.P.,Mirguet O.,Walker A.,Beaufils B.,Ancellin N.,Trottet L.,Beneton V.,Mowat C.G.,Wilkinson M.,Rowland P.,Haslam C.,McBride A.,Homer N.Z.,Baily J.E.,Sharp M.G.,Garden O.J.,Hughes J.,Howie S.E.,Holmes D.S.,Liddle J.,Iredale J.P.
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.
Nat. Med.
22
202-209
2016
562294
Hutchinson J.P.,Rowland P.,Taylor M.R.D.,Christodoulou E.M.,Haslam C.,Hobbs C.I.,Holmes D.S.,Homes P.,Liddle J.,Mole D.J.,Uings I.,Walker A.L.,Webster S.P.,Mowat C.G.,Chung C.W.
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase.
Nat. Commun.
8
15827-15827
2017
562295
Gao J.,Yao L.,Xia T.,Liao X.,Zhu D.,Xiang Y.
Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048.
FASEB J.
32
2036-2045
2018
562296
Kim H.T.,Na B.K.,Chung J.,Kim S.,Kwon S.K.,Cha H.,Son J.,Cho J.M.,Hwang K.Y.
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase.
Cell Chem. Biol.
0
0-0
2018